Head-to-head · WeighScore
CoreAge Rx vs System Labs
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 68.4/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | System Labs |
|---|---|---|
| WeighScore | 89.5/100 | 68.4/100 |
| Grade | B+ | C |
| Site position | #1 | #101 |
| Semaglutide | Product page from $79/mo; navigation $99. Confirm selected quote. | No semaglutide option displayed on the inspected GLP-1 landing page; broader prescribing scope unconfirmed |
| Tirzepatide | From $129/mo advertised; confirm selected charge, supply and renewal. | Advertised $99 first month, then $179/mo for compounded GLP-1/GIP; confirm the exact formulation and prescription supply |
| Coverage | US only; therapy-specific state restrictions apply | General FAQ claims all 50 states, subject to treatment, telehealth and pharmacy limits; specific GLP-1 eligibility needs confirmation |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Site position #101 · C
Strengths
- The landing page distinguishes its advertised $99 first month from the flat $179 ongoing monthly price
- Injection supplies, free two-day temperature-controlled shipping and no per-visit fees are advertised
- The general FAQ and terms name The Pharmacy Hub as a partner; patients still need to confirm their assigned pharmacy
- The landing page includes a compounded-treatment nonapproval disclosure and describes clinician review and ongoing support
What to consider
- The all-dose monthly package does not disclose a numeric dose range, vial concentration or volume, usable injection count or beyond-use date
- Dashboard cancellation on the landing page conflicts with email instructions and a promised future billing portal in the FAQ; no exact notice cutoff is stated
- The FAQ excludes refunds once prescriptions are ordered, while the terms describe different pharmacy-processing stages; clarify the cutoff before paying
- Patient-lab costs and the GLP-1 testing schedule remain unspecified
- The general claim of availability in all 50 states does not confirm eligibility for this particular treatment
- Named advisors and a pharmacy partner do not identify the assigned treating practice, clinician or physical compounder
- Confirm the exact formulation and available payment plans; the advertised monthly package does not settle either
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.